Genoplan
PrivateLast Round
Series B
Sep 2, 2018
Total Funding Raised
$17.51M
Company Overview
Genoplan operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series B round in September 2018.
Genoplan is a biotechnology company that develops genetic test kits and provides personalized health analysis services based on DNA testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, InsurTech
Business Model
B2C
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genoplan Comparables
Compare Genoplan with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| WeGene | 85% | |
| Prenetics | 80% | |
| Mapmygenome | 78% |
For institutional investors. Book with your work email.
Genoplan Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 2, 2018 | ||||
| Series A | Jan 27, 2016 | ||||
| Accelerator | Jun 22, 2015 | ||||
| Crowdfunding | Mar 19, 2015 | ||||
| Grant | Oct 14, 2014 |
For institutional investors. Book with your work email.
Genoplan Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DAYLI Partners | Series B |
| SBVA | Series B, Series A |
| Wonik Investment Partners | Series A |
| Samsung Venture Investment | Series B, Series A |
| Yozma Group | Grant |
| SparkLabs Korea | Series B, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2018
$13M round led by GC Green Cross Holdings.
- Jun 22, 2015
Received funding from SparkLabs Korea.
For institutional investors. Book with your work email.
Genoplan Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genoplan's valuation, stock price, and market status.
Is Genoplan a public or private company?
Genoplan is a private company.
What is the current stock price of Genoplan?
Genoplan is a private company, so its shares have no public market price. Caplight tracks Genoplan's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genoplan worth (valuation)?
Valuation information for Genoplan is not publicly available.
Can I buy Genoplan stock?
Genoplan shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genoplan's last funding round?
Genoplan's most recent funding round was Series B on September 2, 2018.
Who are the main investors in Genoplan?
Key investors in Genoplan include DAYLI Partners, SBVA, Wonik Investment Partners, Samsung Venture Investment, Yozma Group.
Will Genoplan IPO soon?
No public IPO plans have been announced for Genoplan.
How can I track Genoplan secondary market activity?
Caplight tracks bids, offers, and trades in Genoplan's shares on secondary markets.